PP18 is an innovative OXM-based dual agonist targeting GLP-1 and glucagon receptors, exhibiting an EC50 value of 0.487 nM for hGLP-1R and 0.188 nM for hGcgR.
Formula:
C269H426N74O88S2
Target:
Glucagon Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
